Please login to the form below
Lexapro
This page shows the latest Lexapro news and features for those working in and with pharma, biotech and healthcare.
Lundbeck and Otsuka start phase III for Rexulti in bipolar
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
Latest news
-
Lundbeck and Otsuka's Rexulti set for August launch in US
which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
-
NICE backs drug to cut alcohol consumption
its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
-
Lundbeck still feeling effects from Cipralex patent loss
The antidepressant sales dropped another 33% in the third quarter
-
NICE recommends Lundbeck’s alcohol dependency drug
Lundbeck has high hopes for Selincro as it tries to overcome the impact of the loss of patent protection for its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
-
Lundbeck launches Brintellix in first EU market
The first EU launch of Brintellix is another important step for the Danish company as it recovers from the loss of patent protection for its antidepressant Lexapro (escitalopram oxalate), a former ... Clinical trial results suggest Brintellix is at least
More from news
Approximately 2 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
Pharma deals during February 2014
s best selling depression drug Lexapro and another patent cliff looming for Nameda, its Alzheimer's drug in 2015.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Systematic Reviewer - Oxford
-
Negotiable
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Principal Health Economist - North-West
-
Negotiable
-
Medical Writer
-
Salary TBC
-
Account Manager
-
Negotiable
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
Subscribe to our email news alerts
- Is China ready for a pharmaceutical gold rush?
- We've moved!
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- Dragonfly signs Celgene as partner for NK cell platform
- NICE appraisal fees to be introduced despite opposition
- AZ still sees route to approval for Imfinzi in MYSTIC trial
PMHub
Hayward Medical Communications
Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...
Latest intelligence
- Is China ready for a pharmaceutical gold rush?
- Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Quick links
Infographics
